Running Oak Capital LLC Has $15.38 Million Stake in Stryker Corporation (NYSE:SYK)

Running Oak Capital LLC lifted its stake in Stryker Corporation (NYSE:SYK - Free Report) by 7.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,253 shares of the medical technology company's stock after buying an additional 2,710 shares during the period. Running Oak Capital LLC's holdings in Stryker were worth $15,378,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Cullinan Associates Inc. boosted its stake in shares of Stryker by 28.7% in the first quarter. Cullinan Associates Inc. now owns 7,625 shares of the medical technology company's stock valued at $2,838,000 after buying an additional 1,700 shares during the period. Union Savings Bank boosted its stake in shares of Stryker by 5.7% in the first quarter. Union Savings Bank now owns 3,342 shares of the medical technology company's stock valued at $1,244,000 after buying an additional 180 shares during the period. Suncoast Equity Management boosted its stake in shares of Stryker by 1.8% in the first quarter. Suncoast Equity Management now owns 124,123 shares of the medical technology company's stock valued at $46,205,000 after buying an additional 2,173 shares during the period. Weaver Capital Management LLC boosted its stake in shares of Stryker by 1.2% in the first quarter. Weaver Capital Management LLC now owns 3,674 shares of the medical technology company's stock valued at $1,368,000 after buying an additional 44 shares during the period. Finally, Monte Financial Group LLC boosted its stake in shares of Stryker by 14.8% in the first quarter. Monte Financial Group LLC now owns 3,492 shares of the medical technology company's stock valued at $1,210,000 after buying an additional 451 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on SYK shares. Needham & Company LLC reiterated a "buy" rating and issued a $442.00 price target on shares of Stryker in a research note on Friday, March 21st. Citigroup restated a "buy" rating and set a $455.00 target price (up from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Sanford C. Bernstein set a $450.00 target price on Stryker in a research note on Monday, May 5th. Roth Mkm upped their target price on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Finally, Truist Financial upped their target price on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research note on Monday, May 5th. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $427.30.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Up 0.6%

Shares of SYK opened at $375.44 on Friday. Stryker Corporation has a 52 week low of $314.93 and a 52 week high of $406.19. The stock has a market capitalization of $143.30 billion, a price-to-earnings ratio of 50.73, a PEG ratio of 2.83 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. The stock has a fifty day moving average of $374.95 and a 200-day moving average of $375.20.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. During the same period in the prior year, the company earned $2.50 EPS. Stryker's revenue was up 11.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.89%. Stryker's payout ratio is 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.